CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop new antiviral drugs targeting the influenza virus by focusing on its polymerase, a key component for viral replication. The research combines drug design with fundamental studies on the virus's structure and function.
The 2009 H1N1 pandemic and the ongoing threat of highly pathogenic H5N1 strains have focused attention worldwide on the urgent need for effective anti-influenza drug options when the public is not protected by vaccination.
The need is pressing since several circulating strains are resistant to currently stock-piled anti-neuraminidase drugs.
In this project, we will exploit our recent advances in the detailed mechanistic understanding of the structure and function of the viral polymerase, the rep…
EUROPEAN MOLECULAR BIOLOGY LABORATORY
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Austria, WIEN
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
France, GRENOBLE
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
Germany, Marburg
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
